Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.74 USD | -0.51% | -4.49% | +76.85% |
Mar. 22 | Hims & Hers Health Insider Sold Shares Worth $823,055, According to a Recent SEC Filing | MT |
Mar. 15 | Hims & Hers Health Insider Sold Shares Worth $965,016, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2024 * | 1.19B | Sales 2025 * | 1.46B | Capitalization | 3.37B |
---|---|---|---|---|---|
Net income 2024 * | 25M | Net income 2025 * | 54M | EV / Sales 2024 * | 2.64 x |
Net cash position 2024 * | 218M | Net cash position 2025 * | 382M | EV / Sales 2025 * | 2.04 x |
P/E ratio 2024 * |
203
x | P/E ratio 2025 * |
68.5
x | Employees | 1,046 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.03% |
Latest transcript on Hims & Hers Health, Inc.
1 day | -0.51% | ||
1 week | -4.49% | ||
Current month | +20.71% | ||
1 month | +17.20% | ||
3 months | +76.46% | ||
6 months | +153.05% | ||
Current year | +76.85% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 35 | 21-01-19 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 57 | 22-01-23 |
Patrick Carroll
CTO | Chief Tech/Sci/R&D Officer | 66 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Delos Cosgrove
BRD | Director/Board Member | 82 | 21-01-19 |
Director/Board Member | 41 | 17-09-30 | |
Alex Bard
BRD | Director/Board Member | 49 | 21-01-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.95% | 11 M€ | -6.03% | - | |
0.02% | 227 M€ | +4.45% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 15.74 | -0.51% | 3,858,971 |
24-03-26 | 15.82 | -3.00% | 4,741,186 |
24-03-25 | 16.31 | -0.12% | 4,054,842 |
24-03-22 | 16.33 | -2.39% | 3,782,326 |
24-03-21 | 16.73 | +1.52% | 4,776,314 |
Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+76.85% | 3.37B | |
+40.55% | 603M | |
+42.77% | 470M | |
-42.11% | 249M | |
-26.62% | 96.86M |